342 related articles for article (PubMed ID: 1287886)
21. Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor.
Andrews RK; Bendall LJ; Booth WJ; Berndt MC
Platelets; 1995; 6(5):252-8. PubMed ID: 21043709
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster.
Yamamoto H; Vreys I; Stassen JM; Yoshimoto R; Vermylen J; Hoylaerts MF
Thromb Haemost; 1998 Jan; 79(1):202-10. PubMed ID: 9459348
[TBL] [Abstract][Full Text] [Related]
23. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding.
Fujimura Y; Miyata S; Nishida S; Miura S; Kaneda M; Yoshioka A; Fukui H; Katayama M; Tuddenham EG; Usami Y
Thromb Haemost; 1992 Oct; 68(4):464-9. PubMed ID: 1280375
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
26. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
[TBL] [Abstract][Full Text] [Related]
27. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
28. Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction.
Aihara M; Tamura K; Kawarada R; Okawa K; Yoshida Y
Thromb Haemost; 1988 Oct; 60(2):182-7. PubMed ID: 3064358
[TBL] [Abstract][Full Text] [Related]
29. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis.
Kroner PA; Frey AB
Biochemistry; 1996 Oct; 35(41):13460-8. PubMed ID: 8873615
[TBL] [Abstract][Full Text] [Related]
32. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
33. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
34. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
Weinstein M; Vosburgh E; Phillips M; Turner N; Chute-Rose L; Moake J
Blood; 1991 Nov; 78(9):2291-8. PubMed ID: 1932745
[TBL] [Abstract][Full Text] [Related]
35. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
[TBL] [Abstract][Full Text] [Related]
36. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
Matsushita T; Sadler JE
J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
[TBL] [Abstract][Full Text] [Related]
37. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
38. Structure and function of snake venom toxins interacting with human von Willebrand factor.
Matsui T; Hamako J
Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
[TBL] [Abstract][Full Text] [Related]
39. Aurin tricarboxylic acid inhibits adhesion of platelets to subendothelium.
Owens MR; Holme S
Thromb Res; 1996 Jan; 81(2):177-85. PubMed ID: 8822132
[TBL] [Abstract][Full Text] [Related]
40. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
